Please ensure Javascript is enabled for purposes of website accessibility

Cannabis Stocks Would Make a Big Mistake By Doing This 1 Thing

By David Jagielski – Feb 3, 2020 at 12:53PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Aphria even mentioning a possibility of a dividend is surprising, to say the least.

Cannabis stocks have plenty of challenges including trying to generate positive cash flow and struggling to break even.

Cash is a scarce resource for many companies in the sector, one that management teams shouldn't use unless it's going to result in growth or somehow improve their financials. That's why what cannabis producer Aphria (APHA) said on its most recent earnings call was all the more puzzling.

Could Aphria issue a dividend in the future?

As surprising as it sounds, the company's CFO Carl Merton mentioned the possibility of the cannabis producer distributing a dividend to its shareholders in light of its strong results. Aphria has recorded a positive adjusted earnings before interest taxes depreciation and amortization (EBITDA) for three straight quarters, and the company doesn't plan on that streak stopping anytime soon.

Not only is Merton counting on those strong results to drive the company's future growth, but he also mentioned "being in the position to provide an annual return to our shareholders through dividends." While there's no timeline as to when that might happen, it's a remarkable statement to make given the challenges many cannabis companies have had with respect to breaking even. Investors typically expect a dividend in a mature sector where profits are consistent, not in an industry experiencing high growth and rising costs.

Pile of cash.

Image source: Getty Images.

Why it's not a good idea

It's certainly noble of Aphria to want to pay its shareholders a dividend. But given the challenges in the industry, such as the health concerns surrounding vaping products, it's just not a safe strategy.

Once a company starts issuing a dividend, investors come to expect it even though a company is under no obligation to continue paying it. If Aphria were to begin making dividend payments and then a problem arose where it needed to cut or eliminate them, the move would adversely affect its share price. After all, a company doesn't cut its dividend when things are going well.

Perhaps the most important reason for a cannabis company not to pay a dividend is because it diverts cash at a time when it's most opportune to have plenty of it on hand. Cannabis stocks, including Aphria, have fallen heavily over the past six months. The Horizons Marijuana Life Sciences ETF is down 40% during that time while shares of HEXO have fallen 70%, making Aphria's 11% decline look very impressive. 

As a result, valuations in the cannabis industry are the lowest they've ever been. With sufficient cash on hand, Aphria could take over a competitor and instantly improve its growth potential in one big move. That would add a lot more value for investors than a dividend would. While the company could make room for both growth and dividends, growth is what has made the sector what is it today and it's what investors want the company to focus on.

Should investors ditch a pot stock that pays dividends?

Offering a dividend can sometimes do more harm than good. If a cannabis company were to issue dividends so early in the industry's growth, it could be a cause for concern for investors that perhaps the company has run out of ideas as to how to grow the business.

Investors who want dividend income have plenty of stocks from other industries to choose from. When stock prices in the cannabis industry are plummeting, a 1% or even a 5% dividend isn't going to offer much of a reprieve for investors who have lost large chunks of their investments. Focusing on a new growth initiative, however, could help those stocks turn things around.

Aphria's talk of dividends may be years away from being a reality, but it's an important reminder for investors on why it's far too early for cannabis companies to be paying out any profits back out to shareholders just yet.

David Jagielski has no position in any of the stocks mentioned. The Motley Fool recommends HEXO. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aphria Stock Quote
Horizons Marijuana Life Sciences Index ETF Stock Quote
Horizons Marijuana Life Sciences Index ETF
$4.45 (-3.28%) $0.15
HEXO Stock Quote
$0.17 (-2.04%) $0.00

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/01/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.